4.6 Article

A Novel Linc00308/D21S2088E Intergenic Region ALK Fusion and Its Enduring Clinical Responses to Crizotinib

Journal

JOURNAL OF THORACIC ONCOLOGY
Volume 15, Issue 6, Pages 1073-1077

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2020.03.009

Keywords

-

Funding

  1. National Key Research and Development Program of China [2017YFC1308800]
  2. National Natural Science Foundation of China [30900650, 81372501, 81572260, 81773299]
  3. Guangdong Natural Science Foundation [2018A050506036]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available